Bisphosphonates and avascular necrosis of the mandible: case report and review of the literature.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18068657.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Avascular necrosis of the mandible or maxilla is being recognized with increasing frequency in patients who are being treated with bisphosphonates for metastatic cancers. A patient who was treated for avascular necrosis following treatment with bisphosphonates for multiple myeloma is presented. Prophylactic and preventative measures should be instituted prior to commencing treatment with bisphosphonates to minimize the risk of developing avascular necrosis.
Medical subject headings
- Bone Density Conservation Agents
- Diphosphonates
- Mandibular Diseases
- Osteonecrosis